Alprazolam XR (ALPRAZOLAM)
Alprazolam XR (ALPRAZOLAM) is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: Alprazolam XR; Generic name: ALPRAZOLAM; Drug class: Benzodiazepine [EPC].
| Brand name | Alprazolam XR |
|---|---|
| Generic name | ALPRAZOLAM |
| Drug class | Benzodiazepine [EPC] |
| Manufacturer | Mylan Pharmaceuticals Inc. |
| Used for | 1 INDICATIONS AND USAGE Alprazolam XR is indicated for the treatment of panic disorder with or without agoraphobia, in adults. Alprazolam XR is a benzodiazepine indicated for the treatment of panic disorder with or without agoraphobia, in adults. ( 1 ) |
| Dosage | 2 DOSAGE AND ADMINISTRATION • Recommended starting oral dosage is 0.5 mg to 1 mg once daily (preferably in the morning). Depending on the response, the dose may be increased at intervals of 3 to 4 days in increments of no more than 1 mg daily. ( 2.1 ) • Recommended total daily dosage is 3 mg to 6 mg daily. ( 2.1 ) • Swallow tablets whole; do not divide, crush, or chew. ( 2.1 ) • When tapering, decrease dosage by no more than 0.5 mg every 3 days. Some patients may require an even slower dosage re |
| Warnings | WARNING: RISKS FROM CONCOMITANT USE WITH OPIOIDS; ABUSE, MISUSE, AND ADDICTION; and DEPENDENCE AND WITHDRAWAL REACTIONS • Concomitant use of benzodiazepines and opioids may result in profound sedation, respiratory depression, coma, and death. Reserve concomitant prescribing of these drugs for patients for whom alternative treatment options are inadequate. Limit dosages and durations to the minimum required. Follow patients for signs and symptoms of respiratory depression and sedation [see Warnin |
| Active ingredient(s) | ALPRAZOLAM |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1338d1c9-7c75-42ed-95f3-9eb1b6fc51d3 |